Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Withdrawn 2Terminated 2Unknown 1Recruiting 1

Sponsor Class

NIH 7OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × MK 2206 × Clear all
NCT01186705 2015-11-18

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
1 enrolled 4 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01466868 2014-07-10

AKTIL

Centre Leon Berard

Phase 2 Terminated
22 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡